Adeia stock price target maintained at $35 by Rosenblatt on IP strength

Adeia cut revenue guidance to $375 million-$415 million, with a $395 million midpoint, as negotiations on several large license agreements extend into 2027; Rosenblatt maintained its Buy rating and $35 price target. Rosenblatt cited longer negotiation cycles, while management said the high end of guidance remains achievable and declined to rush agreements to meet quarterly targets. The article also notes separate semiconductor-sector developments, including Intel's weak outlook and AMD shares falling 6.5% after Intel's announcement.

Analysis

ADEA’s risk is less that negotiations are failing than that deal timing is becoming too unpredictable for annual guidance to anchor earnings expectations. That can keep a discount on the shares even if agreements eventually close: investors must underwrite both negotiation duration and the economics of each renewal, not just the size of the IP portfolio. Prior eventual signings are evidence against treating delays as cancellations, but do not establish that future deals will close on comparable terms. AI-related licensing value is an option, not yet proof of incremental pricing power or near-term revenue.

Over the next 1–3 months, watch for further guidance changes and evidence that negotiations have converted into signed agreements; a rating and price target are not substitutes for that evidence. Over 6–18 months, the key test is whether semiconductor licensing adds durable, visible growth while media deal timing remains lumpy. Intel’s PC weakness may also create sector-wide pressure, but it does not by itself establish weaker AMD data-center demand. A relative AMD-versus-Intel position is therefore a mix and execution thesis, not a clean read-through from Intel’s outlook.

Key Decisions for Investors

• ADEA: Avoid treating the lower outlook as either a confirmed lost-deal event or a simple timing blip. Stay on the sidelines pending contract conversion and updated guidance; verify signed-deal timing, revenue recognition, and economics before underwriting a recovery.
• ADEA falsifiers: A large agreement signing with guidance stabilization would weaken the delay-risk thesis. Further slippage beyond management’s stated horizon, another guidance cut, or evidence of worse renewal economics would strengthen it.
• AMD/INTC: Consider a small, risk-controlled long AMD/short Intel relative position only if subsequent company disclosures support continued divergence in data-center versus PC exposure. Intel’s weakness could spill across the sector; reduce or exit if AMD’s data-center outlook weakens or Intel’s PC/inventory outlook stabilizes materially.
• Do not pay for ADEA’s AI-IP optionality as though monetization were established. Reassess after disclosed semiconductor agreement wins provide evidence on conversion pace and commercial terms.